Plastic surgeon

Mobeus exits Plastic Surgeon for 5.6x money

Mobeus has sold Plastic Surgeon, the surface repair and restoration specialist, to Polygon Group.

VCT Fundraising
open now

Mobeus VCT Fundraising
Now open

Mobeus VCT Offers 2019/20 -

Plastic Surgeon is the UK’s largest cosmetic surface repair specialist, with particular expertise in fine finishing services. The company provides high quality, long-lasting repairs to any hard surface, including ceramic, UPVC, brick, stone and glass, in diverse industries from house build, through construction and insurance, to facilities management.


Mobeus originally invested £2 million to support the MBO of Plastic Surgeon in 2008 and supported the business through the subsequent recession, which affected its key house-build market. During the investment term, the management team took the company into new markets, changed its culture and invested in technology and marketing. 

Polygon, the acquirer, is the European market leader in property damage restoration, serving a range of sectors including insurance, property management, government and industrial clients. It is wholly owned by Triton, a Scandinavian private equity firm. 

The sale represents a 5.6x money multiple on the Mobeus VCTs’ original £2 million investment and equates to an IRR of 20.5% over the eleven-year investment period. 

Bob Henry, who led the original investment and sat on the Board, said: 

“It was a privilege to back a business so focused on minimising waste in support of a circular economy, not to mention an absolute delight to work with this strong management team led by Rob Mouser. Rob’s focus on sales and productivity has allowed the business to scale effectively despite significant market challenges along the way. The success demonstrates just how important the M is in MBO.”

The shareholders were advised by Momentum Corporate Finance (Alastair Boorman and Richard Double) and TLT (Legal).

(Ends)

10 May 2019

“I truly believe the support we received from Mobeus was unique. Without such a flexible, patient approach, we would not have been able to invest and grow as a business to where we are today.”

Rob Mouser, Plastic Surgeon CEO 

10 May 2019